This clinical trial is focused on studying the prevention of bleeding in patients who are taking blood thinners and need to have one or more teeth removed. The blood thinners involved in this study are known as direct oral anticoagulants and vitamin K antagonists. The treatment being tested is called Tranexamic Acid Oral Solution 5%, which is a liquid medication taken by mouth. The study will compare the effects of this treatment with a placebo to see if it can help reduce bleeding after dental procedures.

The main goal of the study is to find out if Tranexamic Acid Oral Solution 5% can effectively reduce bleeding that is significant enough to be considered clinically important. This includes bleeding in the mouth and face area after having teeth extracted. Participants in the study will be randomly assigned to receive either the tranexamic acid solution or a placebo. The study is designed to be double-blind, meaning neither the participants nor the researchers will know who is receiving the actual treatment or the placebo, to ensure unbiased results.

Throughout the study, participants will be monitored for any bleeding episodes after their dental procedures. The study will also assess how acceptable the medication is to the participants, which means looking at how easy it is for them to take the medication as directed. The study is expected to last for a short period, with the treatment being given for up to seven days. The results will help determine if Tranexamic Acid Oral Solution 5% is a safe and effective option for managing bleeding in patients on blood thinners undergoing tooth extractions.